Phosphodiesterase 4 inhibitor plus metformin is superior to metformin alone for the treatment of polycystic ovary syndrome: A rat model study.

Tohma, Yusuf Aytac; Onalan, Gogsen; Tepeoglu, Merih; Bayraktar, Nilufer; Colak, Eser; Ozcimen, Emel Ebru; Zeyneloglu, Hulusi Bulent

Tohma, Yusuf Aytac; Onalan, Gogsen; Tepeoglu, Merih; Bayraktar, Nilufer; Colak, Eser; Ozcimen, Emel Ebru; Zeyneloglu, Hulusi Bulent.

Afiliación

Tohma YA; Department of Obstetrics and Gynecology, Baskent University School of Medicine, 06490 Ankara, Turkey.
Onalan G; Department of Obstetrics and Gynecology, Baskent University School of Medicine, 06490 Ankara, Turkey.
Tepeoglu M; Department of Pathology, Baskent University School of Medicine, 06490 Ankara, Turkey.
Bayraktar N; Department of Biochemistry, Baskent University School of Medicine, 06490 Ankara, Turkey.
Colak E; Department of Obstetrics and Gynecology, Baskent University School of Medicine, 42080 Konya, Turkey.
Ozcimen EE; Department of Obstetrics and Gynecology, Baskent University School of Medicine, 42080 Konya, Turkey.
Zeyneloglu HB; Department of Obstetrics and Gynecology, Baskent University School of Medicine, 06490 Ankara, Turkey.

Exp Ther Med ; 17(5): 4013-4022, 2019 May.

Article en En | MEDLINE | ID: mdl-30988783

Palabras clave

metformin; obesity; phosphodiesterase 4 inhibitor; polycystic ovary syndrome

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Exp Ther Med Año: 2019 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google